Michael Landsittel, CHIEF FINANCIAL OFFICER at Blueprint Medicines Corp (BPMC), sold 7,700 shares at $107.17 ($824K) on 2024-05-15, disclosed to the SEC on 2024-05-17.
Scheduled sale ($824k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.56 | 1,364 | $145K | 17.6% |
| 2 | $106.56 | 1,364 | $145K | 17.6% |
| 3 | $107.17 | 2,486 | $266K | 32.4% |
| 4 | $107.17 | 2,486 | $266K | 32.4% |
| Total | $106.95 avg | 7,700 | $824K | 100% |
| Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |
| BPMC | SELL | 2024-03-19 | $2.4M | — | Filing → |